Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors
@article{JTD54249, author = {Yenong Cao and Muhammad Zubair Afzal and Keisuke Shirai}, title = {Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors}, journal = {Journal of Thoracic Disease}, volume = {13}, number = {8}, year = {2021}, keywords = {}, abstract = {}, issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/54249} }